EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction

M. Oelke(Medizinische Hochschule Hannover), Alexander Bachmann(University Hospital of Basel), A. Descazeaud(Université de Limoges), Mark Emberton(University College London), Stavros Gravas(University of Thessaly), Martin C. Michel(Johannes Gutenberg University Mainz), James N’Dow(University of Aberdeen), Jørgen Nordling(Herlev Hospital), Jean J. de la Rosette(University of Amsterdam)

European Urology

March 13, 2013

10.1016/j.eururo.2013.03.004

Cited by 1,242

Abstract

Related Papers

Is transurethral resection of the prostate still justified?

Madersbacher, Marberger|British Journal of Urology|1999|386

Long‐term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate: results at 7 years

Peter Gilling, Liam C. Wilson, Colleen J. King et al.|British Journal of Urology|2011|335

Comparison of dutasteride and finasteride for treating benign prostatic hyperplasia: the Enlarged Prostate International Comparator Study (EPICS)

J. Curtis Nickel, Peter Gilling, Teuvo L.J. Tammela et al.|British Journal of Urology|2011|218

Systematic review and meta-analysis of Transurethral Needle Ablation in symptomatic Benign Prostatic Hyperplasia

Carmen Bouza, Teresa López‐Cuadrado, Angeles Magro et al.|BMC Urology|2006|123

Nitric oxide synthase and the lower urinary tract: possible implications for physiology and pathophysiology.

Karin Andersson, Katarina Persson|PubMed|1995|119